Bad news for Marine Polymer Technologies?

I recently blogged on what I feel is a promising new hemostasis agent from Marine Polymer Technologies, the Syvek Patch. We have used the patch and it has performed well as a leave nothing behind agent to achieve puncture site hemostasis-most commonly at the femoral artery.

From MSN:

Vascular Solutions, Inc. (Nasdaq:VASC) announced that the First Circuit of the U.S. Court of Appeals has affirmed the judgment in its favor in its product disparagement litigation with Marine Polymer Technologies...

This appears to be bad news for a small publicly held company.